Value Creation. Experience. Diligence.
Carve Bio works with companies and investors who are seeking to translate therapies from research into clinical trials, build pipelines or partnerships, assess new technologies, scope scientific datasets for regulatory submissions, navigate reimbursement potential, and create value from science or platforms for a wide range of stakeholders.
We work across therapeutic areas, though often with a component of immunology (e.g., autoimmune, fibrosis, inflammation, cancer), kidney disease, ophthalmology, cardiovascular, or in cell therapy or genomic medicines.
working with multiple teams to shape and build data packages to support clinical translation, situates her in a position to connect the dots between science, patients, and business considerations to build strong strategic pipelines. She works to identify synergies for partnerships, ensure that scientific programs create clear value for patients from discovery to the clinic to commercialization, set the value proposition and path to reimbursement, and provide diligence for investors.